Volume 1, Issue 3 (2014)                   2014, 1(3): 157-169 | Back to browse issues page

XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Ghiasi P, Hosseinkhani S, Nafissi S, Khajeh K. SOD1 C6W mutation and exon deletion in an amyotrophic lateral sclerosis patient. Molecular and Biochemical Diagnosis Journal 2014; 1 (3) :157-169
URL: http://mbd.modares.ac.ir/article-8-5229-en.html
1- Department of Biochemistry, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, Iran
2- Department of Neurology, Tehran University of Medical Sciences, Tehran, Iran
Abstract:   (5637 Views)
Background: Despite the genetic heterogeneity reported in familial ALS (FALS), SOD1 gene mutations are the most frequent cause of FALS, accounting for around 20% of familial cases (ALS1) and isolated sporadic cases. Mutant forms of SOD1 exhibit toxicity that promotes the death of motor neurons. It is well documented that FALS produces protein aggregates in the motor neurons of FALS patients, which have been found to be associated to mitochondria. Methods: In this study, we cloned the SOD1 gene, using reverse transcriptase-polymerase chain reaction (RT-PCR) method, from both a healthy control and a living 79 -year-old man with diagnosis of sporadic form of ALS who had shown unusual rapid progression of disease. RNA samples were available from lymphocytes of them. pET28a expression system and BL21 chemically competent Escherichia coli strain as host were used for protein expression. Results: DNA Sequencing data showed both heterozygosis C to G transition at nucleotide position 21 leading to a C6W changing at protein level and a deletion at nucleotides position 73 to 169 leading to complete deletion of exon two.
Full-Text [PDF 305 kb]   (3264 Downloads)    

Received: 2015/12/14 | Accepted: 2014/09/1 | Published: 2015/12/14

Add your comments about this article : Your username or Email:
CAPTCHA

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.